Reaction
Forced Vital Capacity Decreased reporting signals
As of the last recalculation, Forced Vital Capacity Decreased appears in 640 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 132.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 51 | 132.2 | 132.7 |
| Pirfenidone | 128 | 127.5 | 127.9 |
| Nintedanib | 99 | 121.3 | 121.7 |
| Omalizumab | 204 | 113.8 | 114.1 |
| Dutasteride | 17 | 69.8 | 70.0 |
| Tiotropium Bromide | 161 | 50.7 | 50.8 |
| Ipratropium Bromide | 51 | 50.4 | 50.5 |
| Theophylline | 17 | 49.4 | 49.5 |
| Budesonide And Formoterol Fumarate Dihydrate | 120 | 49.3 | 49.3 |
| Fluticasone Propionate And Salmeterol Xinafoate | 76 | 46.6 | 46.6 |
| Theophylline Anhydrous | 17 | 45.8 | 45.8 |
| Timolol | 14 | 38.5 | 38.5 |
| Mepolizumab | 51 | 36.2 | 36.2 |
| Montelukast Sodium | 111 | 35.7 | 35.7 |
| Albuterol Sulfate | 212 | 34.2 | 34.3 |
| Fluticasone Furoate And Vilanterol Trifenatate | 35 | 33.4 | 33.5 |
| Terazosin Hydrochloride | 9 | 33.4 | 33.4 |
| Fluticasone Furoate | 12 | 32.8 | 32.8 |
| Indapamide | 17 | 31.7 | 31.7 |
| Rosuvastatin Calcium | 23 | 27.5 | 27.5 |
| Montelukast | 53 | 22.3 | 22.3 |
| Loperamide Hydrochloride Oral | 6 | 19.3 | 19.3 |
| Mirabegron | 19 | 16.4 | 16.4 |
| Ticagrelor | 13 | 13.5 | 13.5 |
| Dornase Alfa | 4 | 6.7 | 6.7 |